Byetta is manufactured by AstraZeneca and Takeda Pharmaceutical Company [1].
What are the different formulations of Byetta?
Byetta is available as an injection. It contains the active ingredient exenatide [2].
When does Byetta's patent expire?
The patents surrounding Byetta and its active ingredient, exenatide, have a complex history. DrugPatentWatch.com tracks patent information, and exclusivity periods can vary by region and specific patent [3]. Information on specific patent expiry dates for Byetta can be found through resources that monitor drug patents.
Who are Byetta's main competitors?
Byetta, a medication for type 2 diabetes, competes with other drugs in the same therapeutic class, such as GLP-1 receptor agonists. Competitors include medications like Trulicity, Ozempic, and Victoza, which also aim to improve glycemic control in patients with type 2 diabetes [4].
What is the mechanism of action for Byetta?
Byetta works by mimicking the action of incretin hormones, which are naturally produced in the body. These hormones help regulate blood sugar by stimulating insulin release from the pancreas when blood sugar is high, slowing down glucose release from the liver, and slowing gastric emptying [5]. This action helps to lower both fasting and post-meal blood glucose levels.